ORIX - SPONSORED ADR (IX) Fundamental Analysis & Valuation

NYSE:IX • US6863301015

31.23 USD
-0.65 (-2.04%)
At close: Mar 11, 2026
31.23 USD
0 (0%)
After Hours: 3/11/2026, 7:06:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This IX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall IX gets a fundamental rating of 4 out of 10. We evaluated IX against 98 industry peers in the Financial Services industry. There are concerns on the financial health of IX while its profitability can be described as average. IX has a valuation in line with the averages, but on the other hand it scores bad on growth. IX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. IX Profitability Analysis

1.1 Basic Checks

  • In the past year IX was profitable.
  • IX had a positive operating cash flow in the past year.
  • Each year in the past 5 years IX has been profitable.
  • IX had a positive operating cash flow in each of the past 5 years.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

  • The Return On Assets of IX (2.50%) is better than 64.29% of its industry peers.
  • With a Return On Equity value of 9.90%, IX perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • IX has a Return On Invested Capital of 3.15%. This is comparable to the rest of the industry: IX outperforms 53.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IX is significantly below the industry average of 8.33%.
  • The last Return On Invested Capital (3.15%) for IX is above the 3 year average (2.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROIC 3.15%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With a Profit Margin value of 14.49%, IX perfoms like the industry average, outperforming 59.18% of the companies in the same industry.
  • IX's Profit Margin has declined in the last couple of years.
  • IX has a Operating Margin of 19.97%. This is in the better half of the industry: IX outperforms 69.39% of its industry peers.
  • In the last couple of years the Operating Margin of IX has remained more or less at the same level.
  • With a decent Gross Margin value of 42.41%, IX is doing good in the industry, outperforming 63.27% of the companies in the same industry.
  • IX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IX Health Analysis

2.1 Basic Checks

  • IX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IX has less shares outstanding
  • Compared to 5 years ago, IX has less shares outstanding
  • Compared to 1 year ago, IX has an improved debt to assets ratio.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

  • IX has an Altman-Z score of 0.67. This is a bad value and indicates that IX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.67, IX is in line with its industry, outperforming 52.04% of the companies in the same industry.
  • IX has a debt to FCF ratio of 3051.64. This is a negative value and a sign of low solvency as IX would need 3051.64 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 3051.64, IX is not doing good in the industry: 69.39% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.47 is on the high side and indicates that IX has dependencies on debt financing.
  • The Debt to Equity ratio of IX (1.47) is worse than 63.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Altman-Z 0.67
ROIC/WACC0.85
WACC3.69%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

  • A Current Ratio of 0.48 indicates that IX may have some problems paying its short term obligations.
  • The Current ratio of IX (0.48) is worse than 61.22% of its industry peers.
  • IX has a Quick Ratio of 0.48. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IX has a Quick ratio of 0.43. This is in the lower half of the industry: IX underperforms 61.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.43
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IX Growth Analysis

3.1 Past

  • IX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.80%.
  • IX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.09% yearly.
  • IX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
  • Measured over the past years, IX shows a decrease in Revenue. The Revenue has been decreasing by -1.43% on average per year.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%

3.2 Future

  • IX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.
  • The Revenue is expected to grow by 6.36% on average over the next years.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.29%
EPS Next 5Y15.29%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.77%
Revenue Next 5Y6.36%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

More info and screens

Find the best growth stocksShow best growing peers

4

4. IX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.10, IX is valued on the expensive side.
  • Based on the Price/Earnings ratio, IX is valued a bit more expensive than the industry average as 60.20% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, IX is valued at the same level.
  • The Price/Forward Earnings ratio is 14.26, which indicates a correct valuation of IX.
  • IX's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of IX to the average of the S&P500 Index (24.27), we can say IX is valued slightly cheaper.
Industry RankSector Rank
PE 21.1
Fwd PE 14.26
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IX indicates a somewhat cheap valuation: IX is cheaper than 67.35% of the companies listed in the same industry.
  • 69.39% of the companies in the same industry are cheaper than IX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2549.74
EV/EBITDA 10.02
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of IX may justify a higher PE ratio.
  • A more expensive valuation may be justified as IX's earnings are expected to grow with 20.29% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y20.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. IX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.79%, IX has a reasonable but not impressive dividend return.
  • IX's Dividend Yield is a higher than the industry average which is at 2.34.
  • Compared to an average S&P500 Dividend Yield of 1.82, IX pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

  • The dividend of IX is nicely growing with an annual growth rate of 7.63%!
  • IX has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of IX decreased in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

  • IX pays out 31.18% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of IX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.18%
EPS Next 2Y21.71%
EPS Next 3Y20.29%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IX Fundamentals: All Metrics, Ratios and Statistics

ORIX - SPONSORED ADR

NYSE:IX (3/11/2026, 7:06:24 PM)

After market: 31.23 0 (0%)

31.23

-0.65 (-2.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners49.67%
Inst Owner Change4.56%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap34.53B
Revenue(TTM)3.13T
Net Income(TTM)439.75B
Analysts77.5
Price Target32.61 (4.42%)
Short Float %0.07%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.77
Dividend Growth(5Y)7.63%
DP31.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.8%
PT rev (3m)14.89%
EPS NQ rev (1m)-0.72%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.72%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.11%
Revenue NY rev (3m)-1.02%
Valuation
Industry RankSector Rank
PE 21.1
Fwd PE 14.26
P/S 1.79
P/FCF 2549.74
P/OCF 4.17
P/B 1.23
P/tB 1.75
EV/EBITDA 10.02
EPS(TTM)1.48
EY4.74%
EPS(NY)2.19
Fwd EY7.01%
FCF(TTM)0.01
FCFY0.04%
OCF(TTM)7.5
OCFY24.01%
SpS17.4
BVpS25.46
TBVpS17.81
PEG (NY)0.82
PEG (5Y)N/A
Graham Number29.12
Profitability
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROCE 4.53%
ROIC 3.15%
ROICexc 3.5%
ROICexgc 4.93%
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
FCFM 0.07%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Debt/EBITDA 6.49
Cap/Depr 327.15%
Cap/Sales 43.02%
Interest Coverage 250
Cash Conversion 130.12%
Profit Quality 0.49%
Current Ratio 0.48
Quick Ratio 0.43
Altman-Z 0.67
F-Score7
WACC3.69%
ROIC/WACC0.85
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.29%
EPS Next 5Y15.29%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.77%
Revenue Next 5Y6.36%
EBIT growth 1Y1.57%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year12651.2%
EBIT Next 3Y452.45%
EBIT Next 5YN/A
FCF growth 1Y111.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.39%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX FAQ

What is the ChartMill fundamental rating of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


Can you provide the valuation status for ORIX - SPONSORED ADR?

ChartMill assigns a valuation rating of 4 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


Can you provide the profitability details for ORIX - SPONSORED ADR?

ORIX - SPONSORED ADR (IX) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for IX stock?

The Price/Earnings (PE) ratio for ORIX - SPONSORED ADR (IX) is 21.1 and the Price/Book (PB) ratio is 1.23.


How sustainable is the dividend of ORIX - SPONSORED ADR (IX) stock?

The dividend rating of ORIX - SPONSORED ADR (IX) is 7 / 10 and the dividend payout ratio is 31.18%.